D
Dayashankar
About Dayashankar
Dayashankar has 8 years in corporate governance. Holds Director role. Currently with 10 companies, including Forum Pharma Private Limited and Spintron India Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Forum Pharma Private Limited
U24233DL2005PTC141576
|
Director | 06 Aug 2018 | 2005 | Active |
Spintron India Private Limited
U29299DL1996PTC075707
|
Director | 31 Mar 2018 | 1996 | Active |
Gifts Overseas Private Limited
U52100DL2014PTC269164
|
Director | 06 Aug 2018 | 2014 | Active |
Evershine Hospitality Private Limited
U55101DL2005PTC141918
|
Director | 06 Aug 2018 | 2005 | Active |
Forum Sales Private Limited
U74899DL1988PTC030371
|
Director | 07 Sep 2020 | 1988 | Active |
Mars Dairy Products Private Limited
U74899DL1988PTC030380
|
Director | 07 Sep 2020 | 1988 | Active |
Juneja Marketing Private Limited
U74899DL1993PTC054398
|
Director | 06 Aug 2018 | 1993 | Active |
Glory Export Private Limited
U74899DL1994PTC058365
|
Director | 06 Aug 2018 | 1994 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dayashankar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dayashankar
Dayashankar has 8 years in corporate governance. Holds Director role. Currently with 10 companies, including Forum Pharma Private Limited and Spintron India Private Limited. Engaged in General Business. Contributes to corporate operations.
Dayashankar is associated with 10 companies as Director.
Dayashankar has expertise in General Business.
Dayashankar has 8 years in corporate governance.